It may lead to general brain atrophy, especially in frontal areas of the brain, but it could also influence AD pathology specifically through oxidative stress, synaptic dysfunction, impaired amyloid clearance, tau phosphorylation or APOE4 interactions. The gene discussed is MAPT; the disease is Brain atrophy.